COVID-19: all 7,774 studies

Page 10 of 78. Open to participants first (482), then studies with results posted, then the rest; newest registration first within each.

• GLS-5310 Vaccine for the Prevention of SARS-CoV-2 (COVID-19)CompletedNCT04673149Phase 1/2Results posted
• Dose Finding Study to Evaluate The Safety, Tolerability and Immunogenicity of an Inactiviated, Adjuvanted SARS-CoV-2 Virus Vaccine Candidate Against Covid-19 in Healthy SubjectsCompletedNCT04671017Phase 1/2Results posted
• Fluvoxamine for Early Treatment of Covid-19 (Stop Covid 2)CompletedNCT04668950Phase 3Results posted
• A Trial Evaluating the Safety and Effects of an RNA Vaccine ARCT-021 in Healthy AdultsTerminatedNCT04668339Phase 2Results posted
• Silmitasertib (CX-4945) in Patients With Severe Coronavirus Disease 2019 (COVID-19)TerminatedNCT04668209Phase 2Results posted
• RCT of Fomitopsis Officinalis and Trametes Versicolor to Treat COVID-19CompletedNCT04667247Phase 1/2Results posted
• COVID-19 Study Assessing the Virologic Efficacy of REGN10933+REGN10987 Across Different Dose Regimens in Adult Outpatients With SARS-CoV-2 InfectionCompletedNCT04666441Phase 2Results posted
• Symptom-Based Markers for COVID-19 TransmissionCompletedNCT04665245Results posted
• Predicting Severity and Disease Progression in Influenza-like Illness (Including COVID-19)TerminatedNCT04664075Results posted
• Predictors of Recovery and the App-Facilitated Tele-Rehabilitation (AFTER) Program for COVID-19 SurvivorsCompletedNCT04663945Not applicableResults posted
• Evaluating Safety, Pharmacokinetics and Clinical Benefit of Silmitasertib (CX-4945) in Subjects With Moderate COVID-19CompletedNCT04663737Phase 2Results posted
• Phase I/II Safety, Dose Finding & Antiviral Activity of RD-X19 in Mild/Moderate Outpatient COVID-19CompletedNCT04662671Not applicableResults posted
• COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master ProtocolCompletedNCT04662086Phase 2Results posted
• COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Camostat Sub-ProtocolTerminatedNCT04662073Phase 2Results posted
• COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Acebilustat Sub-ProtocolCompletedNCT04662060Phase 2Results posted
• A COVID-19 Study to Evaluate Safety and Pharmacokinetics of COVID-HIGIV Administered in Healthy AdultsCompletedNCT04661839Phase 1Results posted
• A Study of Auxora in Patients With Critical COVID-19 PneumoniaTerminatedNCT04661540Phase 2Results posted
• Reward Re-Training: A New Treatment to Address Reward Imbalance During the COVID-19 PandemicCompletedNCT04661410Not applicableResults posted
• Evaluation of Aerosol in a Dental ClinicCompletedNCT04659928Phase 4Results posted
• Factors Affecting Mortality in Critical Patients Admitted to Intensive Care Unit Due to Coronavirus Disease 2019CompletedNCT04659876Results posted
• SARS-CoV-2/COVID-19 Prevalence StudyCompletedNCT04658121Results posted
• At-Home Infusion Using Bamlanivimab in Participants With Mild to Moderate COVID-19TerminatedNCT04656691Phase 4Results posted
• Assessing Safety, Hospitalization and Efficacy of rNAPc2 in COVID-19CompletedNCT04655586Phase 2/3Results posted
• Camostat With Bicalutamide for COVID-19TerminatedNCT04652765Phase 1Results posted
• LYT-100 in Post-acute COVID-19 Respiratory DiseaseTerminatedNCT04652518Phase 2Results posted
• A Phase 2b/3, Randomized, Observer-Blinded, Placebo-Controlled, Multicenter Clinical Study Evaluating the Efficacy and Safety of Investigational SARS-CoV-2 mRNA Vaccine CVnCoV in Adults 18 Years of Age and OlderCompletedNCT04652102Phase 2/3Results posted
• COVID-19 Thrombosis Prevention Trials: Post-hospital ThromboprophylaxisCompletedNCT04650087Phase 3Results posted
• AirFLO2 Treatment for Hypoxia and/or Tachypnea in Patients With COVID-19TerminatedNCT04649775Not applicableResults posted
• A Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19CompletedNCT04649151Phase 2/3Results posted
• CRISOL Contigo: a Multi-level Intervention to Reduce the Disproportionate Toll of COVID-19 Among Latino Communities in Philadelphia.CompletedNCT04646616Not applicableResults posted
• Ivermectin for Severe COVID-19 ManagementCompletedNCT04646109Phase 3Results posted
• A Placebo Controlled Trial of Bempegaldesleukin (BEMPEG; NKTR-214) With Standard of Care in Patients With Mild COVID-19CompletedNCT04646044Phase 1Results posted
• The Efficacy and Safety of SCTA01 in Hospitalized Patients With Severe COVID-19TerminatedNCT04644185Phase 2/3Results posted
• A Phase II/III Study of SargramostimCompletedNCT04642950Phase 2/3Results posted
• Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Adults at High Risk of SARS-CoV-2 ExposureTerminatedNCT04642638Phase 2/3Results posted
• Adaptive COVID-19 Treatment Trial 4 (ACTT-4)CompletedNCT04640168Phase 3Results posted
• Contrast Enhanced Ultrasound in COVID-19CompletedNCT04640038Phase 3Results posted
• NeuroCovid Rehab and Recovery Related to COVID-19 DiagnosisCompletedNCT04638673Phase 2Results posted
• Study To antagOnize Plasminogen Activator Inhibitor-1 in Severe COVID-19TerminatedNCT04634799Phase 1/2Results posted
• A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 IllnessCompletedNCT04634409Phase 2Results posted
• Exploratory Ph I Trial of the Active IMP in Healthy Volunteers in Relation to COVID-19CompletedNCT04632706Phase 1Results posted
• SARS-CoV-2-Neutralizing Monoclonal COVID-19 Antibody DZIF-10c by InhalationTerminatedNCT04631705Phase 1/2Results posted
• SARS-CoV-2-Neutralizing Monoclonal COVID-19 Antibody DZIF-10c by InfusionCompletedNCT04631666Phase 1/2Results posted
• The LAVA (Lateral Flow Antigen Validation and Applicability) Study for COVID-19CompletedNCT04629157Not applicableResults posted
• Phase III Double-blind, Placebo-controlled Study of AZD7442 for Post- Exposure Prophylaxis of COVID-19 in AdultsCompletedNCT04625972Phase 3Results posted
• Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult.CompletedNCT04625725Phase 3Results posted
• The Potential of Camostat in COVID-19TerminatedNCT04625114Phase 2Results posted
• Intravenous Infusion of CAP-1002 in Patients With COVID-19CompletedNCT04623671Phase 2Results posted
• Study of Plasma Exchange in Severe COVID-19CompletedNCT04623255Phase 2Results posted
• The Study of the Use of Nintedanib in Slowing Lung Disease in Patients With Fibrotic or Non-Fibrotic Interstitial Lung Disease Related to COVID-19CompletedNCT04619680Phase 4Results posted
• Thromboembolic Risk Screening in Patients With Cancer and COVID-19CompletedNCT04616846Not applicableResults posted
• Cannabidiol in Patients With COVID-19 and Cardiovascular Disease or Risk FactorsTerminatedNCT04615949Phase 2/3Results posted
• A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in AdultsCompletedNCT04614948Phase 3Results posted
• Diagnostic Performance of an Antigen Test for SARS-CoV-2 Infection (COVID-19)TerminatedNCT04610489Not applicableResults posted
• Treat COVID-19 Patients With RegadenosonCompletedNCT04606069Phase 1/2Results posted
• A Triple Combination Antiviral Coronavirus Therapy (TriACT) for COVID-19TerminatedNCT04605588Phase 2Results posted
• ACTION ON COVID-19: A Study to Test Whether BI 764198 Helps Lung Health of People Hospitalised With COVID-19TerminatedNCT04604184Phase 2Results posted
• Study of Niclosamide in Moderate and Severe Hospitalized Coronavirus-19 (COVID-19) PatientsCompletedNCT04603924Phase 2/3Results posted
• A Phase 2/3 Study to Evaluate the Efficacy and Safety of CT-P59 in Patients With Mild to Moderate SARS-CoV-2 InfectionCompletedNCT04602000Phase 2/3Results posted
• The Prevent Severe COVID-19 (PRESECO) StudyCompletedNCT04600895Phase 3Results posted
• COVID-19 Tests: Nasopharyngeal Swab vs Saliva Collected With Salivette® Cortisol for Viral RNA Sampling for RT-qPCRCompletedNCT04599959Not applicableResults posted
• Study to Evaluate Efficacy and Safety of "VIRACIDE" IN THE MANAGEMENT OF CORONA VIRUS DISEASE 2019 (COVID-19)CompletedNCT04596085Not applicableResults posted
• COVID-19, Chronic Adaptation and Response to Exercise (COVID-CARE)Active, not recruitingNCT04595773Not applicableResults posted
• Immune Modulators for Treating COVID-19CompletedNCT04593940Phase 3Results posted
• This is a Phase 1 Study to Evaluate the Safety,Tolerability and Virology of CT P59 in Patients With Mild Symptoms of Symptoms of Coronavirus Disease (COVID-19)CompletedNCT04593641Phase 1Results posted
• Dulce Digital-COVID Aware (DD-CA) Discharge Texting Platform for US/Mexico Border Hispanics With Diabetes + COVID-19CompletedNCT04591015Not applicableResults posted
• Study of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized PatientsCompletedNCT04590586Phase 3Results posted
• GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19)CompletedNCT04590547Phase 2Results posted
• Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Japanese AdultsCompletedNCT04588480Phase 4Results posted
• Supporting Family Members With Severe Grief Reaction During the COVID-19 PandemicCompletedNCT04588415Not applicableResults posted
• Mouth Rinses for Inactivation of COVID-19TerminatedNCT04584684Phase 2Results posted
• ACTIV-5 / Big Effect Trial (BET-B) for the Treatment of COVID-19CompletedNCT04583969Phase 2Results posted
• ACTIV-5 / Big Effect Trial (BET-A) for the Treatment of COVID-19CompletedNCT04583956Phase 2Results posted
• Camostat Efficacy vs. Placebo for Outpatient Treatment of COVID-19 (CAMELOT)CompletedNCT04583592Phase 2Results posted
• PK and Safety of Remdesivir for Treatment of COVID-19 in Pregnant and Non-Pregnant Women in the USCompletedNCT04582266Results posted
• COVID-19 Watch + COVID-19 PulseCompletedNCT04581863Not applicableResults posted
• Prolonged Prone Positioning for COVID-19-induced Acute Respiratory Distress Syndrome (ARDS)CompletedNCT04581811Not applicableResults posted
• Lift Mobile Mindfulness for COVID-19 Distress SymptomsCompletedNCT04581200Not applicableResults posted
• Fostamatinib for Hospitalized Adults With COVID-19CompletedNCT04579393Phase 2Results posted
• Description of the Population With Genitourinary Tumors and COVID-19CompletedNCT04578132Results posted
• Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002)CompletedNCT04575597Phase 2/3Results posted
• Efficacy and Safety of Molnupiravir (MK-4482) in Hospitalized Adult Participants With COVID-19 (MK-4482-001)TerminatedNCT04575584Phase 2/3Results posted
• CRISIS2: A Phase 2 Study of the Safety and Antiviral Activity of Brequinar in Non-hospitalized Pts With COVID-19CompletedNCT04575038Phase 2Results posted
• Safety and Efficacy of Trans Sodium Crocetinate (TSC) in SARS-CoV-2 (COVID-19) Infected SubjectsCompletedNCT04573322Phase 1/2Results posted
• Dose Ranging Trial to Assess Safety and Immunogenicity of V590 (COVID-19 Vaccine) in Healthy Adults (V590-001)TerminatedNCT04569786Phase 1Results posted
• Rapid Turnaround, Home-based Saliva Testing for COVID-19CompletedNCT04568122Not applicableResults posted
• Study of AZD1222 for the Prevention of COVID-19 in JapanCompletedNCT04568031Phase 1/2Results posted
• Supporting the Health and Well-being of Children With Intellectual and Developmental Disability During COVID-19 PandemicCompletedNCT04565509Not applicableResults posted
• A Trial of GC4419 in Patients With Critical Illness Due to COVID-19TerminatedNCT04555096Phase 2Results posted
• Safety and Efficacy of Rayaldee for Treating Mild to Moderate COVID-19CompletedNCT04551911Phase 2Results posted
• Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)CompletedNCT04551898Phase 2Results posted
• Engaging Patients in Colon Cancer Screening Decisions During COVID-19CompletedNCT04548531Not applicableResults posted
• Study to Evaluate the Safety and Efficacy of Liquid Alpha1-Proteinase Inhibitor (Human) in Hospitalized Participants With Coronavirus Disease (COVID-19)TerminatedNCT04547140Phase 2Results posted
• Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC)CompletedNCT04546581Phase 3Results posted
• VIR-7831 for the Early Treatment of COVID-19 in OutpatientsCompletedNCT04545060Phase 2/3Results posted
• Observational Study of Convalescent Plasma for Treatment of Veterans With COVID-19CompletedNCT04545047Results posted
• Trial of Famotidine & N-Acetyl Cysteine for Outpatients With COVID-19TerminatedNCT04545008Phase 1Results posted
• Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19CompletedNCT04542694Phase 3Results posted
• Lung Ultrasound Implementation in the Management of Patients Hospitalized With COVID-19CompletedNCT04542421Not applicableResults posted
• Using BCG to Protect Senior Citizens During the COVID-19 PandemicCompletedNCT04542330Phase 3Results posted

← COVID-19 overview